(19)
(11) EP 4 399 303 A1

(12)

(43) Date of publication:
17.07.2024 Bulletin 2024/29

(21) Application number: 22800032.9

(22) Date of filing: 08.09.2022
(51) International Patent Classification (IPC): 
C12N 15/113(2010.01)
C12N 15/86(2006.01)
C12N 15/11(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 15/111; C12N 15/113; C12N 2310/20; C12N 15/86; C12N 2330/51; C12N 2760/20143; C12N 2760/20151; C12N 2760/20152
(86) International application number:
PCT/US2022/076106
(87) International publication number:
WO 2023/039468 (16.03.2023 Gazette 2023/11)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 08.09.2021 US 202163241964 P

(71) Applicants:
  • Beam Therapeutics, Inc.
    Cambridge, MA 02139 (US)
  • Ran, Fei
    Cambridge, Massachusetts 02139 (US)
  • Lin, ChieYu
    Cambridge, Massachusetts 02139 (US)

(72) Inventors:
  • RAN, Fei
    Cambridge, Massachusetts 02139 (US)
  • LIN, ChieYu
    Cambridge, Massachusetts 02139 (US)

(74) Representative: De Clercq & Partners 
Edgard Gevaertdreef 10a
9830 Sint-Martens-Latem
9830 Sint-Martens-Latem (BE)

   


(54) VIRAL GUIDE RNA DELIVERY